Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

07/08/2025 07:34

Aug 7 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             18.87               18.25            88.00    
                 (+3.4 pct)          (+0.6 pct)       (-6.4 pct)  
  Operating        14 mln                2.75             5.20    
                 (-99.5 pct)         (-16.5 pct)      (-75.3 pct) 
  Recurring        417 mln               3.01             6.00    
                 (-86.1 pct)         (-13.7 pct)      (-71.8 pct) 
  Net              271 mln               1.75             3.40    
                 (-84.5 pct)         (-30.1 pct)      (-75.6 pct) 
  EPS             7.13 yen            46.32 yen        89.79 yen  
  Ann Div                            190.00 yen       190.00 yen  
  -Q2 div                            115.00 yen        95.00 yen  
  -Q4 div                             75.00 yen        95.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T